Top

11-07-2018 | Axial spondyloarthritis | Article

The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis

Journal: Arthritis Research & Therapy

Authors: Sizheng Zhao, Daniel Thong, Natasha Miller, Stephen J. Duffield, David M. Hughes, Laura Chadwick, Nicola J. Goodson

Publisher: BioMed Central

Abstract

Background

Depression is common among patients with axial spondyloarthritis (axSpA), but reports of its prevalence are highly variable. We performed a systematic review to (i) describe the prevalence of depression in axSpA, (ii) compare its prevalence between axSpA, ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA) cohorts, and (iii) compare disease activity and functional impairment between those with and without depression.

Methods

We searched Medline, PubMed, Web of Science, PsycINFO, CINAHL Plus, the Cochrane library and conference abstracts of the European League Against Rheumatism, British Society for Rheumatology and American College of Rheumatology using a predefined protocol in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Meta-analysis was performed using quality-effects model.

Results

Fifteen original articles and one abstract were included for analysis; 14 studies described AS cohorts and two nr-axSpA. Three screening criteria and one diagnostic criterion were used to define depression. Prevalence ranged from 11 to 64% depending on criteria and thresholds used. Pooled prevalence of at least moderate depression was 15% using the Hospital Anxiety and Depression Scale (HADS) threshold of ≥ 11. The prevalence of depression was similar between axSpA, AS and nr-axSpA cohorts. Patients with depression had significantly worse disease activity, including higher BASDAI by 1.4 units (95% CI 1.0 to 1.9), ASDAS by 0.5 units (95% CI 0.3 to 0.7) and ESR by 3.5 mm/h (95% CI 0.6 to 6.4). They also had greater functional impairment with higher BASFI and BASMI by 1.2 units (95% CI 0.6 to 1.8) and 0.6 units (95% CI 0.3 to 0.8), respectively. Mean age of each study cohort inversely correlated with depression prevalence.

Conclusions

Depression is common among axSpA patients and is associated with more severe disease activity and functional impairment. Identifying and managing depression should form part of their holistic care. Further longitudinal studies are needed to explore the impact of depression on treatment outcomes and axSpA treatment on symptoms of depression.

van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27(4):361–8.CrossRefPubMed

Rudwaleit M, Jurik AG, Hermann KG, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis. 2009;68(10):1520–7.CrossRefPubMed

van Tubergen A, Weber U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol. 2012;8(5):253–61.CrossRefPubMed

Martindale J, Shukla R, Goodacre J. The impact of ankylosing spondylitis/axial spondyloarthritis on work productivity. Best Pract Res Clin Rheumatol. 2015;29(3):512–23.CrossRefPubMed

Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–45.CrossRefPubMed

Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD open. 2015;1(Suppl 1):e000053.CrossRefPubMedPubMedCentral

Prince MJ, Harwood RH, Blizard RA, Thomas A, Mann AH. Impairment, disability and handicap as risk factors for depression in old age. The gospel oak project V. Psychol Med. 1997;27(2):311–21.CrossRefPubMed

Piccinelli M, Wilkinson G. Gender differences in depression. Critical review. Br J Psychiatry. 2000;177:486–92.CrossRefPubMed

Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.CrossRefPubMedPubMedCentral

10.

Zhao S, Thong D, Duffield SJ, Hughes D, Goodson NJ. Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study. Rheumatol Int. 2018;38(3):375–81.CrossRefPubMedPubMedCentral

11.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.CrossRefPubMed

12.

Barendregt JJ, Doi SA. MetaXL user guide (version 5.3). 2016. Available from: http://www.epigear.com/index_files/MetaXL%20User%20Guide.pdf. Accessed Feb 2018.

13.

Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974–8.CrossRefPubMed

14.

Stern AF. The hospital anxiety and depression scale. Occup Med (Lond). 2014;64(5):393–4.CrossRef

15.

World Health Organization. The Zung Self-Rating Depression Scale. 2018. Available from: http://www.who.int/substance_abuse/research_tools/zungdepressionscale. Accessed Feb 2018.

16.

Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012;184(3):E191–6.CrossRefPubMedPubMedCentral

17.

Zhang S-L, Gao F, Chen Z-H, Yan Q, Lin H. Influence of psychological status on back pain and clinical assessments in Chinese ankylosing spondylitis patients: a cross-sectional study. Int J Clin Exp Med. 2016;9(12):23624–33.

18.

Kilic G, Kilic E, Ozgocmen S. Relationship between psychiatric status, self-reported outcome measures, and clinical parameters in axial spondyloarthritis. Medicine (Baltimore). 2014;93(29):e337.CrossRef

19.

Hyphantis T, Kotsis K, Tsifetaki N, Creed F, Drosos AA, Carvalho AF, et al. The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis. Clin Rheumatol. 2013;32(5):635–44.CrossRefPubMed

20.

Healey EL, Haywood KL, Jordan KP, Garratt A, Packham JC. Impact of ankylosing spondylitis on work in patients across the UK. Scand J Rheumatol. 2011;40(1):34–40.CrossRefPubMed

21.

Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA. Disease and psychological status in ankylosing spondylitis. Rheumatology. 2006;45(10):1288–93.CrossRefPubMed

22.

Xu X, Shen B, Zhang A, Liu J, Da Z, Liu H, et al. Anxiety and depression correlate with disease and quality-of-life parameters in Chinese patients with ankylosing spondylitis. Patient Prefer Adherence. 2016;10:879–85.CrossRefPubMedPubMedCentral

23.

Gunaydin R, Goksel Karatepe A, Cesmeli N, Kaya T. Fatigue in patients with ankylosing spondylitis: relationships with disease-specific variables, depression, and sleep disturbance. Clin Rheumatol. 2009;28(9):1045–51.CrossRefPubMed

24.

Chan CYY, Tsang HHL, Lau CS, Chung HY. Prevalence of depressive and anxiety disorders and validation of the hospital anxiety and depression scale as a screening tool in axial spondyloarthritis patients. Int J Rheum Dis. 2017;20(3):317–25.CrossRefPubMed

25.

Dougados M, Logeart I, Szumski A, Coindreau J, Jones H. Evaluation of whether extremely high enthesitis or bath ankylosing spondylitis disease activity index (BASDAI) scores suggest fibromyalgia and confound the anti-TNF response in early non-radiographic axial spondyloarthritis. Clin Exp Rheumatol. 2017;35(Suppl 105(3)):50–3.PubMed

26.

Hakkou J, Rostom S, Aissaoui N, Berrada KR, Abouqal R, Bahiri R, et al. Psychological status in Moroccan patients with ankylosing spondylitis and its relationships with disease parameters and quality of life. J Clin Rheumatol. 2011;17(8):424–8.CrossRefPubMed

27.

Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int. 2011;31(6):795–800.CrossRefPubMed

28.

Zou Q, Jiang Y, Mu F, Shi Y, Fang Y. Correlation of axial Spondyloarthritis with anxiety and depression. Med Sci Monit. 2016;22:3202–8.CrossRefPubMedPubMedCentral

29.

Rodriguez-Lozano C, Gantes MA, Gonzalez B, Hernandez-Beriain JA, Naranjo A, Hernandez V, et al. Patient-acceptable symptom state as an outcome measure in the daily care of patients with ankylosing spondylitis. J Rheumatol. 2012;39(7):1424–32.CrossRefPubMed

30.

Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S, et al. Co-occurrence and characteristics of patients with axial Spondyloarthritis who meet criteria for fibromyalgia: results from a UK National Register. Arthritis Rheum. 2017;69(11):2144–50.CrossRef

31.

Jiang Y, Yang M, Lv Q, Qi J, Lin Z, Liao Z, et al. Prevalence of psychological disorders, sleep disturbance and stressful life events and their relationships with disease parameters in Chinese patients with ankylosing spondylitis. Clin Rheumatol. 2018;37(2):407–14.CrossRefPubMed

32.

Ates A, Dortbas F, Karaaslan Y. FRI0202 the relationship between disease activity, functional index, sleep quality, anxiety, depression, fatigue and quality of life in patients with ankylosing spondylitis. Ann Rheum Dis. 2015;74:497–8.CrossRef

33.

Healey EL, Haywood KL, Jordan KP, Garratt AM, Packham JC. Disease severity in ankylosing spondylitis: variation by region and local area deprivation. J Rheumatol. 2010;37(3):633–8.CrossRefPubMed

34.

Sandhu J, Packham JC, Healey EL, Jordan KP, Garratt AM, Haywood KL. Evaluation of a modified arthritis self-efficacy scale for an ankylosing spondylitis UK population. Clin Exp Rheumatol. 2011;29(2):223–30.PubMed

35.

Yacoub YI, Amine B, Abid H, Hajjaj-Hassouni N. Assessment of depression in Moroccan patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71(Supp:3):568.

36.

Aissaoui N, Rostom S, Hakkou J, Berrada Ghziouel K, Bahiri R, Abouqal R, et al. Fatigue in patients with ankylosing spondylitis: prevalence and relationships with disease-specific variables, psychological status, and sleep disturbance. Rheumatol Int. 2012;32(7):2117–24.CrossRefPubMed

37.

Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49(2):124–38.CrossRefPubMed

38.

Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology. 2013;52(12):2136–48.CrossRefPubMed

39.

Yildiz M, Batmaz I, Sula B, Ucmak D, Sariyildiz MA, Daggulli M, et al. Sexual dysfunction in male patients with Behget's disease. Acta Reumatologica Portuguesa. 2016;41(1):56–61.PubMed

40.

Woo AK. Depression and anxiety in pain. Rev Pain. 2010;4(1):8–12.CrossRefPubMedPubMedCentral

41.

Zhao S, Hider S, Sparks C, Matcham F, Galloway J, Estrach C, et al. Association between anxiety and depression and rheumatoid arthritis outcome: results from an inception early rheumatoid arthritis cohort. Arthritis Rheum. 2015;67(suppl 10):2684.